Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CIV-IT-25-03-051856 | Other Identifier | Eudamed |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a two-phase study evaluating the Eurosets arterial and venous cannulas for use during cardiopulmonary bypass (CPB) procedures. Phase 1 is a pilot study focused on assessing cannula safety. Phase 2 is a pivotal study aimed at confirming safety and evaluating efficacy through comparison with Medtronic cannulas (control group).
The results will be compared for non-inferiority with those obtained using the control group cannulas.
The Clinical Investigation is a Two Phases clinical investigation consisting of a pre-Market, Pilot, Interventional, not Randomized, Monocentric Investigation to Evaluate the Safety of PVC Arterial Cannula and PVC Venous Cannula (Class III Medical Devices) intended to be used during Cardiopulmonary Bypass (CPB) procedure followed by a pre-Market, Pivotal, Interventional, Randomized, Non- inferiority, Monocentric Investigation to confirm the Safety and evaluate the Performance of the same cannulas.
The aim of these investigations are: 1) to evaluate safety of Eurosets Venous Cannula and Arterial Cannula in patients subjected to CPB and 2) to evaluate the performance and safety of Arterial Cannula and Venous Cannula intended to be used during CPB procedure. The results obtained will be compared by non-inferiority to the results obtained by Medtronic cannulae (control group).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Eurosets Arterial and Venous Cannula | Experimental | Phase 1: All enrolled subjects will undergo cardiopulmonary bypass using the investigational Eurosets arterial and venous cannulas to evaluate the safety. Phase 2: Participants will undergo cardiopulmonary bypass using the investigational Eurosets arterial and venous cannulas to confirm safety and to evaluate the performance. |
|
| Control Arterial and Venous Cannula | Active Comparator | Phase 2: Participants will undergo cardiopulmonary bypass using commercially available arterial and venous cannulas currently used in standard clinical practice. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Eurosets Venous and Arterial Cannula | Device | Phase 1: Use of investigational Eurosets arterial and venous cannulas during CPB to assess safety and preliminary performance.The Arterial cannulae are designed for insertion in the ascending Aorta. For this Investigation the arterial cannula is reinforced-long curved with flange tip, 3/8" connector with luer lock, 24 Fr.The Venous Cannulae are designed to be used for vena cava and right atrium blood drainage during CPB surgery. For this Investigation the venous cannula is dual stage without connector, lighthouse tip, 32/40 Fr. Phase 2: Use of investigational PVC arterial and venous cannulas during cardiopulmonary bypass (CPB) to confirm safety and evaluate performance compared to control group. For Investigation device: same of phase 1. For Control Group: the Arterial Cannula is EOPA (Medtronic), 24 Fr; the Venous Cannula is Two stage MC2 (Medtronic), 32/40 Fr. |
| Measure | Description | Time Frame |
|---|---|---|
| Phase 1: Safety of Eurosets Arterial and Venous Cannulas | Number and type of adverse events over the duration of the investigation. | At Visit 1 (Pre and during surgical procedure), at Visit 2 (24 hours post-surgical procedure) and at Visit 3 (within 6-7 days post-surgical procedure) |
| Phase 2: Performance of Eurosets Arterial Cannulas | For Arterial cannula: the performance of the Eurosets Arterial Cannulacerebral oximetry (rSO2) will be monitored during CPB using near infrared spectroscopy (NIRS). Delta rSO2 (will be calculated as the percentage) (rate of decrease of rSO2 from pre-clamping) will be compared to delta rSO2 of control arterial cannula. | Time points during CPB: 1st: pre-clamping/CPB initiation, 2nd: pre-weaning |
| Phase 2: Performance of Eurosets Venous Cannulas | For Venous cannula: the performance of the Eurosets Venous Cannula, Central Venous Pressure (CVP) values will be monitored during CPB. Results will be compared to control venous cannula. | Time points during CPB: 1st: pre-clamping/CPB initiation (full flow), 2nd: 10 minutes post-clamping, 3rd: 30 minutes post-clamping. |
| Measure | Description | Time Frame |
|---|---|---|
| Phase 1: Clinical Parameters collected for safety: pH | Clinical parameters monitored with pH value | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: pCO2 |
| Measure | Description | Time Frame |
|---|---|---|
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: pH | Clinical parameters monitored with pH value | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Prof. Giuseppe Nasso | Contact | +39 080 5644111 | gnasso@libero.it |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Anthea Hospital GVM Care & Research | Recruiting | Bari | BA | 70124 | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29489210 | Result | Ismail A, Semien G, Sharma S, Collier SA, Miskolczi SY. Cardiopulmonary Bypass. 2024 Aug 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK482190/ | |
| 18635371 | Result | von Segesser LK, Ferrari E, Delay D, Maunz O, Horisberger J, Tozzi P. Routine use of self-expanding venous cannulas for cardiopulmonary bypass: benefits and pitfalls in 100 consecutive cases. Eur J Cardiothorac Surg. 2008 Sep;34(3):635-40. doi: 10.1016/j.ejcts.2008.05.037. Epub 2008 Jul 16. |
| Label | URL |
|---|---|
| \[Yichao et al., 2006\] Yichao Teng, HaiShu Ding, Qingcheng Gong, Zaishen Jia, Lan Huang, "Monitoring cerebral oxygen saturation during cardiopulmonary bypass using near-infrared spectroscopy: the relationships with body temperature and perfusion rate," J. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Phase 1: Pilot, not Randomized, Monocentric one arm Clinical Investigation with pre-market medical device Phase 2: Pivotal, Randomized, Non-inferiority, Monocentric, two arm Clinical Investigation with pre-market medical device
Not provided
Not provided
Not provided
Not provided
|
| Control Arterial and Venous Cannulas | Device | Phase 2: Use of commercially available arterial and venous cannulas as comparator devices to evaluate the performance of the investigational PVC Arterial and Venous Cannulas during cardiopulmonary bypass (CPB) procedures. the control cannulas are EOPA 24Fr (Medtronic) as Arterial Cannula and Two Stage MC2 32/40Fr (Medtronic) as Venous Cannula. |
|
Clinical parameters: pCO2 recorded with mmHg |
| At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: pO2 | Clinical parameters: pO2 recorded with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: Blood Flow | Clinical parameters: Blood flow recorded with L/min | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: Mean arterial pressure (MAP) | Clinical parameters: MAP recorded with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: Mixed venous oxygen saturation (SvO2) | Clinical parameters: SvO2 recorded with percentage (%) | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: Arterial oxygen saturation (SaO2) | Clinical parameters: SaO2 monitored with percentage | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Clinical Parameters collected for safety: Vacuum level | Clinical parameters: Vacuum level monitored with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Vital sign collected for safety: body temperature | Vital signs: Body Temperature recorded with Celsius degrees (T°) | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery), at Unscheduled Visit(s). |
| Phase 1: Vital sign collected for safety: Heart Rate | Vital signs: Heart Rate recorded with beats/min | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Vital Sign collected for safety: Blood Flow | Vital Sign: Blood flow recorded with L/min | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Vital sign collected for safety: Diastolic pressure | Vital signs: Diastolic pressure recorded with mmHg | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Vital sign collected for safety: Sistolic pressure | Vital signs: Sistolic pressure recorded with mmHg | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Vital sign collected for safety: SpO2 | Vital signs: SpO2 recorded with percentage (%) | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Device deficiencies/incidents collected for safety | Device deficiencies/incidents: recorded with number of Device Deficiencies or Incidents | At Visit 1 Day 1 (Day of surgery): pre-CPB; 1st time point: Pre-clamping/CPB initiation; 2nd time point: 10 minutes post-clamping; 3rd time point: 30 minutes post-clamping; (pre) weaning/decannulation. |
| Phase 1: Concomitant medications collected for safety | Concomitant medications: Medications administered (dosage) during the study period. | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Phase 1: Drainage pressure collected for safety | Drainage pressure: venous pressure compared to blood flow recorded with mmHg | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping. |
| Phase 1: Reinfusion pressure collected for safety | Reinfusion pressure: arterial pressure compared to blood flow recorded with mmHg | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping. |
| Phase 1: Adequacy of tissue perfusion collected for safety | Adequacy of tissue perfusion recorded with levels of blood lactate | At Visit 1 Day 1 (Day of surgery): (pre) weaning/ decannulation |
| Phase 1: Patient's metabolic condition collected for safety: indexed oxygen delivery (DO2i ) | Patient's metabolic condition DO2i recorded with ml/min/m2 | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Patient's metabolic condition collected for safety: oxygen consuption (VO2) | Patient's metabolic condition VO2 recorded with ml/min | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Patient's metabolic condition collected for safety: oxygen extraction (O2ER) | Patient's metabolic condition O2ER recorded with percentage (%) | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Patient's metabolic condition collected for safety: venous oxygen saturation (SvO2) | Patient's metabolic condition SvO2 recorded with percentage (%) | At visit 1 Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Patient's metabolic condition coillected for safety: arterial oxygen saturation (SaO2) | Patient's metabolic condition SaO2 recorded with percentage (%) | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 1: Drainage efficacy of the venous cannula collected for safety | Drainage efficacy of the venous cannula recorded with levels of bilirubin | At Visit 0 (from day -3 to day -1 of surgical procedure) and Visit 2 (24 hours post-surgical procedure) |
| Phase 1: Drainage efficacy of the venous cannula collected for safety | Drainage efficacy of the venous cannula recorded with levels of creatinine | At Visit 0 (from day -3 to day -1 of surgical procedure) and Visit 2 (24 hours post-surgical procedure) |
| Phase 1: Drainage efficacy of the venous cannula collected for safety | Drainage efficacy of the venous cannula recorded with levels of transaminases | At Visit 0 (from day -3 to day -1 of surgical procedure) and Visit 2 (24 hours post-surgical procedure) |
| Phase 1: Duration of CPB procedure and clamping collected for safety | Duration of CPB procedure and clamping recorded with Time (minutes) | At Visit 1 Day 1 (day of surgery): (pre) weaning/ decannulation. |
| Phase 1: (de)cannulation difficulty collected for safety | (de)cannulation difficulty recorded with 5-likert Scale (from 1 - very easy to 5 - very difficult) completed by the anesthesiologist/perfusionist/physician who performed the procedure at Visit 1. | At Visit 1 Day 1 (day of surgery): (pre) weaning/ decannulation |
| Phase 1: Integrity of arterial and venous cannula at decannulation collected for safety | Integrity of arterial and venous cannula at decannulation will be evaluated by the anesthesiologist/perfusionist/physician who performed the procedure and recorded with YES or NO. | At Visit 1 Day 1 (day of surgery): (pre) weaning/ decannulation |
| Phase 1: Presence of clots or thrombi in arterial and venous cannula at decannulation collected for safety | Presence of clots or thrombi in arterial and venous cannula at decannulation. The presence of clots or thrombi will be recorded with YES or NO on the eCRF. | At Visit 1 Day 1 (day of surgery): (pre) weaning/ decannulation |
| Phase 1: Hospitalization stay collected for safety | The number of hospitalization days will be recorded up to patient discharge. | At Visit 3: Pre-discharge (within 6-7 days post-surgical procedure) |
| Phase 2: Drainage pressure (Pdrain) collected for non-inferiority with control group | Drainage pressure (Pdrain) recorded with mmHg. Results compared with control Venous Cannula. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Reinfusion pressure (Pout) collected for non-inferiority with control group | Reinfusion pressure recorded with mmHg. Results compared with control Arterial Cannula. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Adequacy of tissue perfusion collected for non-inferiority with control group | Adequacy of tissue perfusion recorded with levels of blood lactate. Results compared with control group | At Visit 1. Day 1 (Day of surgery): (pre) weaning/decannulation. |
| Phase 2: Patient's metabolic condition collected for non-inferiority with control group: indexed oxygen delivery (DO2i) | Patient's metabolic condition DO2i recorded with ml/min/m2. Results compared with control group. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Patient's metabolic condition collected for non-inferiority with control group: oxygen consumption (VO2) | Patient's metabolic condition VO2 recorded with ml/min. Results compared with control group. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Patient's metabolic condition collected for non-inferiority with control group: oxygen extraction (O2ER) | Patient's metabolic condition O2ER recorded with percentage (%). Results compared with control group. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Patient's metabolic condition collected for non-inferiority with control group: venous oxygen saturation (SVO2) | Patient's metabolic condition SVO2 recorded with percentage (%). Results compared with control group. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Patient's metabolic condition collected for non-inferiority with control group: arterial oxygen ssaturation (SaO2) | Patient's metabolic condition SaO2 recorded with percentage (%). Results compared with control group. | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Phase 2: Drainage efficacy of the venous cannula collected for non-inferiority with control group | Drainage efficacy of the venous cannula recorded with levels of bilirubin. Results compared with control group. | At screening/baseline (Visit 0): Within 3 days before the day of surgery. At Visit 2: 24 hours post-surgical procedure. At Visit 3: before discharge (6-7 days post-surgical procedure). |
| Phase 2: Drainage efficacy of the venous cannula collected for non-inferiority with control group | Drainage efficacy of the venous cannula recorded with levels of creatinine. Results compared with control group. | At screening/baseline (Visit 0): Within 3 days before the day of surgery. At Visit 2: 24 hours post-surgical procedure. At Visit 3: before discharge (6-7 days post-surgical procedure). |
| Phase 2: Drainage efficacy of the venous cannula collected for non-inferiority with control group | Drainage efficacy of the venous cannula recorded with levels of transaminases. Results compared with control group. | At screening/baseline (Visit 0): Within 3 days before the day of surgery. At Visit 2: 24 hours post-CPB. At Visit 3: before discharge (6-7 days post-surgical procedure). |
| Phase 2: Duration of CPB procedure and clamping time collected for non-inferiority with control group | Duration of CPB procedure and clamping time recorded with Time (minutes). Results compared with control group. | At Visit 1. Day 1 (Day of Surgery): (pre) weaning/decannulation. |
| Phase 2: (de)cannulation difficulty collected for non-inferiority with control group | (de)cannulation difficulty recorded with 5-likert Scale (from 1 - very easy to 5 - very difficult) completed by the anesthesiologist/perfusionist/physician. Results compared with control group. | At Visit 1. Day 1 (Day of Surgery): (pre) weaning/decannulation. |
| Phase 2: Integrity of arterial and venous cannula at decannulation collected for non-inferiority with control group | Integrity of arterial and venous cannula at decannulation recorded with YES or NO. | At Visit 1. Day 1 (Day of Surgery): (pre) weaning/decannulation. |
| Phase 2: Presence of clots or thrombi in arterial and venous cannula at decannulation collected for non-inferiority with control group | Presence of clots or thrombi in arterial and venous cannula at decannulation recorded with YES or NO on the eCRF. Results compared with control cannulae. | At Visit 1. Day 1 (Day of Surgery): (pre) weaning/decannulation. |
| Phase 2: Hospitalization stay collected for non-inferiority with control group | Hospitalization stay recorded with number of hospitalization days. Results compared with control group | At Visit 3 (End of Study). Pre-discharge (6-7 days post-surgical procedure). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: pCO2 |
Clinical parameters: pCO2 recorded with mmHg |
| At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: pO2 | Clinical parameters: pO2 recorded with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: Bloof flow | Clinical parameters: Blood flow recorded with L/min | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: Mean arterial Pressure (MAP) | Clinical parameters: MAP recorded with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: Mixed venous oxygen saturation (SvO2) | Clinical parameters: SvO2 recorded with percentage (%) | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: Arterial oxygen saturation (SaO2) | Clinical parameters: SaO2 monitored with percentage (%) | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of clinical parameters: Vaccum Level | Clinical parameters: Vacuum level monitored with mmHg | At Visit 1. Day 1 (Day of surgery): 1st time point: Pre-clamping/CPB initiation, 2nd time point: 10 minutes post-clamping, 3rd time point: 30 minutes post-clamping, (pre) weaning/ decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of vital sign: Body temperature | Description: Vital signs: Body Temperature recorded with Celsius degree (T°) | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of vital sign: Heart Rate | Vital signs: Heart Rate recorded with beats/min | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of vital sign: Blood flow | Vital Sign: Blood flow recorded with L/min | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of vital sign: diastolic pressure | Vital signs: Diastolic pressure recorded with mmHg | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of vital sign: sistolic pressure | Vital signs: Sistolic pressure recorded with mmHg | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal). Monitoring of vital sign: SpO2 | Vital signs: SpO2 recorded with percentage (%) | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of Device deficiencies/incidents | Device deficiencies/incidents recorded with number of Device Deficiencies or Incidents | At Visit 1 Day 1 (Day of surgery): pre-CPB; 1st time point: Pre-clamping/CPB initiation; 2nd time point: 10 minutes post-clamping; 3rd time point: 30 minutes post-clamping; (pre) weaning/decannulation. |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of adverse events, and serious adverse events unrelated to study device | Number and type of adverse events, and serious adverse events unrelated to study device over the duration of the investigation. | At Visit 1 (Pre and during surgical procedure), at Visit 2 (24 hours post-surgical procedure) and at Visit 3 (within 6-7 days post-surgical procedure) |
| Safety Endpoint during Phase 2 (Pivotal): Monitoring of concomitant medications | Concomitant medications: Medications administered (dosage) during the study period. | At Visit 0 (from day -3 to day -1), Day of Surgery - Visit 1 (Day 0), Visit 2 (24 hours after surgery), Visit 3 (6-7 days after surgery). |
| 28970635 | Result | Sarkar M, Prabhu V. Basics of cardiopulmonary bypass. Indian J Anaesth. 2017 Sep;61(9):760-767. doi: 10.4103/ija.IJA_379_17. |
| 31585674 | Result | Authors/Task Force Members; Kunst G, Milojevic M, Boer C, De Somer FMJJ, Gudbjartsson T, van den Goor J, Jones TJ, Lomivorotov V, Merkle F, Ranucci M, Puis L, Wahba A; EACTS/EACTA/EBCP Committee Reviewers; Alston P, Fitzgerald D, Nikolic A, Onorati F, Rasmussen BS, Svenmarker S. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019 Dec;123(6):713-757. doi: 10.1016/j.bja.2019.09.012. Epub 2019 Oct 2. No abstract available. |
| 32437215 | Result | Lamelas J, Aberle C, Macias AE, Alnajar A. Cannulation Strategies for Minimally Invasive Cardiac Surgery. Innovations (Phila). 2020 May/Jun;15(3):261-269. doi: 10.1177/1556984520911917. Epub 2020 May 21. |
| 35412158 | Result | Narasaki S, Miyoshi H, Nakamura R, Sumii A, Watanabe T, Otsuki S, Tsutsumi YM. Venous cannula occlusion during cardiopulmonary bypass recognized by ultrasonography of the internal jugular vein. JA Clin Rep. 2022 Apr 12;8(1):29. doi: 10.1186/s40981-022-00519-2. |
| 31576396 | Result | Wahba A, Milojevic M, Boer C, De Somer FMJJ, Gudbjartsson T, van den Goor J, Jones TJ, Lomivorotov V, Merkle F, Ranucci M, Kunst G, Puis L; EACTS/EACTA/EBCP Committee Reviewers. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg. 2020 Feb 1;57(2):210-251. doi: 10.1093/ejcts/ezz267. No abstract available. |